Axsome Therapeutics (NASDAQ:AXSM), Affimed N.V. (NASDAQ:AFMD), XBiotech (NASDAQ:XBIT) and ADMA Biologics (NASDAQ:ADMA) have been selected for addition to the NASDAQ Biotechnology Index, as part of the annual index evaluation.
All the Company’s additions will become effective prior to the market open on December 23, 2019.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.